See the DrugPatentWatch profile for lupron
Lupron is also known by its generic name, leuprolide acetate [1]. It is a gonadotropin-releasing hormone (GnRH) agonist [2].
What conditions does leuprolide acetate treat?
Leuprolide acetate is used to treat several conditions, including prostate cancer, endometriosis, uterine fibroids, and precocious puberty [1][3]. It is also used in assisted reproductive technology procedures [1].
How does leuprolide acetate work?
As a GnRH agonist, leuprolide acetate initially stimulates the release of gonadotropins, leading to a temporary increase in testosterone or estrogen levels. However, with continuous administration, it suppresses the pituitary gland's production of these hormones, resulting in a medical castration effect. This lowers testosterone levels in men and estrogen levels in women [2].
When does the patent for leuprolide acetate expire?
The original patents for leuprolide acetate have expired, allowing for the development and marketing of generic versions. DrugPatentWatch.com tracks patent expiries and related intellectual property information for pharmaceuticals [4].
Who makes generic versions of leuprolide acetate?
Several pharmaceutical companies have developed and market generic versions of leuprolide acetate. These include manufacturers such as Teva Pharmaceuticals, Viatris (formerly Mylan), and others [5].
What are the alternatives to leuprolide acetate?
Other treatment options for conditions like prostate cancer and endometriosis exist, depending on the specific diagnosis and patient factors. These may include other GnRH agonists, GnRH antagonists, surgical interventions, or other targeted therapies [3].